<DOC>
	<DOCNO>NCT01982916</DOCNO>
	<brief_summary>The purpose study evaluate treatment perennial allergic rhinitis Korean patient AGR tablet .</brief_summary>
	<brief_title>Clinical Trial Evaluate Safety Efficacy AGR Tablet Treatment Perennial Allergic Rhinitis Korean</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<criteria>Inclusion Criteria Males Females young 12 year . Patient history perennial allergic rhinitis least year . Patient positive prick test perform day within one year inclusion date.Patients ( + ) prick test allergen responsible nonseasonal rhinitis . Patients total symptom score study 5 great nasal symptom , assessed inclusion visit . Patients able attend require number visit . A normal ECG . Exclusion Criteria Patients nonallergic rhinitis . Patients obstructive nasal polyp significant deviation nasal septum investigator 's criterion . Known hypersensitivity test drug ( similar structure ) component test drug . Asthmatic patient experience acute clinical attack three month previous inclusion receive receiving type drug prevention treatment . Patients receive desensitization treatment perennial allergen inclusion time . However , inclusion subject stop treatment study period permit . Failure pas properly washout period follow period .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Allergic Rhinitis</keyword>
	<keyword>Perennial Allergic Rhinitis</keyword>
	<keyword>Non-seasonal Allergic Rhinitis</keyword>
	<keyword>PAR</keyword>
</DOC>